Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Free Report) shares hit a new 52-week high during trading on Friday after HC Wainwright raised their price target on the stock from $190.00 to $200.00. HC ...
William Blair cut their Q1 2025 earnings per share estimates for Axsome Therapeutics in a report issued on Tuesday, February ...
Investor's Business Daily on MSN11h
These Biotech Stocks Aren't Profitable But Still Make Elite IBD 50A handful of biotech stocks made an elite list despite being unprofitable. But many show robust sales growth and constructive ...
17hon MSN
Goldman Sachs analysts listed the stocks with the largest increases and decreases in short interest since the U.S. election day. Analysts looked through short interest data reflecting positions as of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback